Therapeutics And Clinical Risk Management

杂志介绍

Therapeutics And Clinical Risk Management杂志介绍

《Therapeutics And Clinical Risk Management》是一本以English为主的开放获取国际优秀期刊，中文名称治疗学和临床风险管理，本刊主要出版、报道医学-HEALTH CARE SCIENCES & SERVICES领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.3，最新CiteScore 指数为5.3。

本刊近期中国学者发表的论文主要有：

• LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis

  Author: Zuo, Tao; Jiang, Ping; Fu, Jun; Zhang, Yongjian

• Research on the Influence of the Allogeneic Bone Graft in Postoperative Recovery After MOWHTO: A Retrospective Study

  Author: Zhong, Rui; Yu, Gang; Wang, Yingming; Fang, Chao; Lu, Shuai; Liu, Zhilin; Gao, Jingyu; Yan, Chengyuan; Zhao, Qichun

• Identifying the Risk Factors for Postoperative Sore Throat After Endotracheal Intubation for Oral and Maxillofacial Surgery

  Author: Zheng, Zhou-peng; Tang, Su-lin; Fu, Shao-lan; Wang, Qian; Jin, Li-wei; Zhang, Yan-li; Huang, Rong-rong

• Thoracic Paravertebral Block Decreased Body Temperature in Thoracoscopic Lobectomy Patients: A Randomized Controlled Trial

  Author: Yan, Yanhong; Geng, Jiao; Cui, Xu; Lei, Guiyu; Wu, Lili; Wang, Guyan

英文介绍

Therapeutics And Clinical Risk Management杂志英文介绍

Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.

The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature.

As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication.

The journal does not accept study protocols, animal-based or cell line-based studies.